Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2026)
Intelligent Bio Solutions (INBS) posted Liabilities and Shareholders Equity of $11.94 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 44.8% from $8.25 million a year earlier but down 19.7% from the prior quarter.
Powered by 
Analysis
Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Intelligent Bio Solutions has reported Liabilities and Shareholders Equity for 24 quarters.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -11.4% (FY2021 to FY2026).
- In prior fiscal years, Intelligent Bio Solutions' Liabilities and Shareholders Equity was $8.25 million in FY2025 (-40.1%), $13.78 million in FY2024 (+33.1%), $10.35 million in FY2023 (-16.2%) and $12.35 million in FY2022 (-43.5%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $8.25 million in fiscal Q4 2025 to a high of $19.11 million in fiscal Q1 2022 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last three quarters, with growth averaging 17.2% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q2 2026, with growth of 103.3%; the weakest was fiscal Q2 2024, with a decline of 51.1%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $14.86 million (Q3 2026), $17.65 million (Q2 2026) and $10.04 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Intelligent Bio Solutions | 2.46 Mn | -11.02 Mn | 536,583.00 | 11.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.94 Mn |
| Mar 31, 2026 | 14.86 Mn |
| Dec 31, 2025 | 17.65 Mn |
| Sep 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 8.25 Mn |
| Mar 31, 2025 | 9.58 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 11.73 Mn |
| Jun 30, 2024 | 13.78 Mn |
| Mar 31, 2024 | 17.04 Mn |
| Dec 31, 2023 | 8.83 Mn |
| Sep 30, 2023 | 8.70 Mn |
| Jun 30, 2023 | 10.35 Mn |
| Mar 31, 2023 | 10.67 Mn |
| Dec 31, 2022 | 18.05 Mn |
| Sep 30, 2022 | 10.16 Mn |
| Jun 30, 2022 | 12.35 Mn |
| Mar 31, 2022 | 14.36 Mn |
| Dec 31, 2021 | 15.24 Mn |
| Sep 30, 2021 | 19.11 Mn |
API Access
Intelligent Bio Solutions Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "INBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();